tiprankstipranks
MicroPort Scientific Corp. (HK:0853)
:0853
Want to see HK:0853 full AI Analyst Report?

MicroPort Scientific (0853) Price & Analysis

4 Followers

0853 Stock Chart & Stats

HK$11.67
HK$0.08(1.48%)
At close: 4:00 PM EST
HK$11.67
HK$0.08(1.48%)

Bulls Say, Bears Say

Bulls Say
Cash Flow Management1H recurring NP turned positive at US$1.2mn, and OCF outflow narrowed by 66% due to prudent opex controls and non-core asset disposals.
Export PerformanceStrong export momentum in Medbot, Cardioflow, and vascular segments.
Bears Say
Financial OutlookSales estimates for 2025-27 have been reduced by 2% each due to a more conservative outlook on the TAVI segment.
Sales Performance1H sales fell by 2% YoY with declines in Cardiovascular, Ortho, CRM, Neuro, Endo segments.

MicroPort Scientific News

0853 FAQ

What was MicroPort Scientific Corp.’s price range in the past 12 months?
MicroPort Scientific Corp. lowest stock price was HK$6.63 and its highest was HK$16.28 in the past 12 months.
    What is MicroPort Scientific Corp.’s market cap?
    MicroPort Scientific Corp.’s market cap is HK$13.11B.
      When is MicroPort Scientific Corp.’s upcoming earnings report date?
      MicroPort Scientific Corp.’s upcoming earnings report date is Aug 28, 2026 which is in 75 days.
        How were MicroPort Scientific Corp.’s earnings last quarter?
        MicroPort Scientific Corp. released its earnings results on Mar 31, 2026. The company reported HK$0.399 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.399.
          Is MicroPort Scientific Corp. overvalued?
          According to Wall Street analysts MicroPort Scientific Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does MicroPort Scientific Corp. pay dividends?
            MicroPort Scientific Corp. pays a Annually dividend of HK$0.043 which represents an annual dividend yield of N/A. See more information on MicroPort Scientific Corp. dividends here
              What is MicroPort Scientific Corp.’s EPS estimate?
              MicroPort Scientific Corp.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does MicroPort Scientific Corp. have?
              MicroPort Scientific Corp. has 1,917,379,600 shares outstanding.
                What happened to MicroPort Scientific Corp.’s price movement after its last earnings report?
                MicroPort Scientific Corp. reported an EPS of HK$0.399 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.561%.
                  Which hedge fund is a major shareholder of MicroPort Scientific Corp.?
                  Currently, no hedge funds are holding shares in HK:0853
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    MicroPort Scientific Stock Smart Score

                    Company Description

                    MicroPort Scientific Corp.

                    MicroPort Scientific Corporation, an investment holding company founded in Shanghai, China, in 1998, is a global enterprise dedicated to the development, manufacturing, and commercialization of medical devices. Its operations span across China, North America, Europe, other Asian nations, and South America. The company's diverse product portfolio is structured into several key divisions. The Cardiovascular Devices segment provides solutions for coronary artery diseases, including advanced coronary stents, their associated delivery systems, and various balloon catheters. Its Orthopedics Devices division offers reconstructive joint replacements, spine and trauma implants, and specialized surgical instruments. The Cardiac Rhythm Management Business focuses on devices for diagnosing and treating heart rhythm disorders and heart failure, such as defibrillators, cardiac resynchronization therapy devices, and pacemakers. MicroPort's Endovascular and Peripheral Vascular Devices segment develops interventional treatments for conditions like thoracic and abdominal aortic aneurysms, peripheral vascular diseases, and aortic dissection. The Neurovascular Devices segment provides therapeutic and access tools specifically designed for neurovascular ailments. Within the Heart Valve Business, offerings include the VitaFlow Transcatheter aortic valve and its delivery system, the VitaFlow Liberty Transcatheter aortic valve implantation and retrieval systems, the Alwide Plus Balloon Catheter, alongside various other transcatheter and surgical valves for aortic, mitral, and tricuspid applications. Furthermore, the Surgical Robot Business is actively engaged in the design, engineering, and market introduction of sophisticated surgical robotics, incorporating elements such as robot ontology, control algorithms, electrical engineering, image-based navigation, and precision imaging. Lastly, the Surgical Devices segment is responsible for the research, development, production, and sale of general surgical instruments.

                    MicroPort Scientific (0853) Earnings & Revenues

                    0853 Stock 12 Month Forecast

                    Average Price Target

                    HK$14.94
                    ▲(28.02% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"HK$6","19":"HK$19","9.25":"HK$9.25","12.5":"HK$12.5","15.75":"HK$15.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.94,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$14.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$10.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,9.25,12.5,15.75,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.67,8.464615384615385,9.259230769230768,10.053846153846154,10.848461538461539,11.643076923076922,12.437692307692307,13.232307692307693,14.026923076923076,14.821538461538461,15.616153846153846,16.410769230769233,17.205384615384617,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.67,8.22923076923077,8.788461538461538,9.347692307692308,9.906923076923077,10.466153846153846,11.025384615384615,11.584615384615384,12.143846153846154,12.703076923076923,13.262307692307692,13.821538461538461,14.38076923076923,{"y":14.94,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.67,7.887692307692308,8.105384615384615,8.323076923076924,8.54076923076923,8.758461538461539,8.976153846153846,9.193846153846154,9.411538461538461,9.62923076923077,9.846923076923076,10.064615384615385,10.282307692307693,{"y":10.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.76,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.76,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.21,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.82,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.12,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":10.68,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.54,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.71,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.67,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Peijia Medical Ltd.
                    Acotec Scientific Holdings Limited
                    LifeTech Scientific Corporation
                    Yestar Healthcare Holdings Co Ltd
                    Shanghai Heartcare Medical Technology Corp. Ltd. Class H

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks